Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
975 GBX | +1.46% | +3.17% | -42.07% |
Apr. 24 | Jefferies Cuts CVS Group PT, Maintains at Hold | MT |
Apr. 24 | Investec cuts Hipgnosis Songs Fund to 'hold' | AN |
Sales 2024 * | 671M 839M | Sales 2025 * | 717M 897M | Capitalization | 699M 875M |
---|---|---|---|---|---|
Net income 2024 * | 42M 52.54M | Net income 2025 * | 53M 66.31M | EV / Sales 2024 * | 1.37 x |
Net Debt 2024 * | 222M 278M | Net Debt 2025 * | 179M 224M | EV / Sales 2025 * | 1.23 x |
P/E ratio 2024 * |
17.3
x | P/E ratio 2025 * |
13.2
x | Employees | 9,100 |
Yield 2024 * |
0.81% | Yield 2025 * |
0.88% | Free-Float | 98.46% |
Latest transcript on CVS Group plc
1 day | +1.46% | ||
1 week | +3.17% | ||
1 month | -1.02% | ||
3 months | -41.96% | ||
6 months | -32.67% | ||
Current year | -42.07% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Fairman
CEO | Chief Executive Officer | 57 | 18-07-31 |
Robin Alfonso
DFI | Director of Finance/CFO | 45 | 19-11-05 |
Richard Killen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Deborah Kemp
CHM | Chairman | 62 | 18-01-01 |
David Wilton
BRD | Director/Board Member | 61 | 21-09-23 |
Richard Fairman
CEO | Chief Executive Officer | 57 | 18-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.84% | 1 M€ | -.--% | ||
0.04% | 773 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 975 | +1.46% | 144,331 |
24-04-24 | 961 | +1.16% | 914,266 |
24-04-23 | 950 | +0.11% | 582,890 |
24-04-22 | 949 | -0.32% | 398,044 |
24-04-19 | 952 | +0.74% | 247,896 |
Delayed Quote London S.E., April 25, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-42.07% | 857M | |
-35.01% | 128M |
- Stock Market
- Equities
- CVSG Stock